The DOI matches its Crossref record.
Precursor Balancing for Metabolic Engineering of Lycopene Production in Escherichia coli
Abstract
One issue that must be addressed in the rational design of metabolic pathways is the elimination of potential bottlenecks in the upstream pathways. We have reconstructed the isoprenoid pathway to overproduce the carotenoid lycopene in Escherichia coli. Here we show that the distribution between pyruvate and glyceraldehyde 3-phosphate (G3P), the originating precursors of the isoprenoid pathway, is a major factor that can limit isoprenoid production yields in E. coli. In particular, alterations in the central metabolism that redirect flux from pyruvate back to G3P enhance lycopene production, while alterations that channel carbon flux away from the G3P pool have the opposite effect. These results suggest that G3P may be limiting in the biosynthesis of lycopene, and modifications that achieve a more equitable distribution between the two precursors are able to increase the lycopene yield in metabolically engineered E. coli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Engineering a mevalonate pathway in Escherichia coli for production of terpenoids
Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D., & Keasling, J. D. (2003) · Nature Biotechnology · doi:10.1038/nbt833 · Cited by 1,725
Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli
Ajikumar, P. K., Xiao, W.-H., Tyo, K. E. J., Wang, Y., Simeon, F., Leonard, E., Mucha, O., Phon, T. H., Pfeifer, B., & Stephanopoulos, G. (2010) · Science · doi:10.1126/science.1191652 · Cited by 1,677
Programming cells by multiplex genome engineering and accelerated evolution
Wang, H. H., Isaacs, F. J., Carr, P. A., Sun, Z. Z., Xu, G., Forest, C. R., & Church, G. M. (2009) · Nature · doi:10.1038/nature08187 · Cited by 1,529
Catalytic Conversion of Carbohydrates to Initial Platform Chemicals: Chemistry and Sustainability
Mika, L. T., Cséfalvay, E., & Németh, Á. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00395 · Cited by 1,320
Metabolic engineering of Escherichia coli using CRISPR–Cas9 meditated genome editing
Li, Y., Lin, Z., Huang, C., Zhang, Y., Wang, Z., Tang, Y.-J., Chen, T., & Zhao, X. (2015) · Metabolic Engineering · doi:10.1016/j.ymben.2015.06.006 · Cited by 484
Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli
Alper, H., Jin, Y.-S., Moxley, J. F., & Stephanopoulos, G. (2005) · Metabolic Engineering · doi:10.1016/j.ymben.2004.12.003 · Cited by 450
Terpenoids: Opportunities for Biosynthesis of Natural Product Drugs Using Engineered Microorganisms
Ajikumar, P. K., Tyo, K., Carlsen, S., Mucha, O., Phon, T. H., & Stephanopoulos, G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700151b · Cited by 447
Production of isoprenoid pharmaceuticals by engineered microbes
Chang, M. C. Y., & Keasling, J. D. (2006) · Nature Chemical Biology · doi:10.1038/nchembio836 · Cited by 387
Natural Colorants for Food and Nutraceutical Uses
Delgado-Vargas, F., & Paredes-Lopez, O. (2002) · CRC Press eBooks · doi:10.1201/9781420031713 · Cited by 385
Methylerythritol Phosphate Pathway of Isoprenoid Biosynthesis
Zhao, L., Chang, W.-C., Xiao, Y., Liu, H.-W., & Liu, P. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052010-100934 · Cited by 353
Metabolic Engineering of Escherichia coli for Natural Product Biosynthesis
Yang, D., Park, S. Y., Park, Y. S., Eun, H., & Lee, S. Y. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.11.007 · Cited by 352
Metabolic Engineering for the Production of Natural Products
Pickens, L. B., Tang, Y., & Chooi, Y.-H. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114209 · Cited by 343
Engineering central metabolic modules of Escherichia coli for improving β-carotene production
Zhao, J., Li, Q., Sun, T., Zhu, X., Xu, H., Tang, J., Zhang, X., & Ma, Y. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2013.02.002 · Cited by 325
Metabolic engineering towards biotechnological production of carotenoids in microorganisms
P., L., & C., S.-D. (2002) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-1101-x · Cited by 309
Metabolic Engineering: Past and Future
Woolston, B. M., Edgar, S., & Stephanopoulos, G. (2013) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061312-103312 · Cited by 292
Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug
Liu, C., Zhao, Y., & Wang, Y. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0452-0 · Cited by 158
Weathers, P. J., Elkholy, S., & Wobbe, K. K. (2006) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1079/ivp2006782 · Cited by 97
Genetic engineering of artemisinin biosynthesis: prospects to improve its production
Abdin, M. Z., & Alam, P. (2015) · Acta Physiologiae Plantarum · doi:10.1007/s11738-015-1771-5 · Cited by 25
Chemistry, biosynthesis and biological activity of artemisinin and related natural peroxides
Rydén, A.-M., & Kayser, O. (2007) · Topics in Heterocyclic Chemistry · doi:10.1007/7081_2007_085 · Cited by 16
Metadata
- Authors
- Farmer, W. R., & Liao, J. C.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2001-02-02
- Volume
- 17
- Issue
- 1
- Pages
- 57-61
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W2072042166
- Cited by
- 213
- References
- 0
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.